Thus, the purpose of this study was to compare the plasma NGAL, MMP-9, IL-1β, and hs-CRP levels in different clinical presentations of coronary heart disease (CHD) and to evaluate the relationship between those biomarkers and the severity of coronary stenosis in patients without kidney disease. The gene discussed is IL1B; the disease is coronary stenosis.